Belgium· BE-AMP-SAM520871-00
Tookad 183 mg
A padeliporfin product containing padeliporfin dipotassium, registered in Belgium by Steba Biotech. The same ATC class is registered in 8 of our 19 countries.
Checked against FAMHP / AFMPS (Belgium) on
Informational only — not a medical device.
Where it is registered
Padeliporfin is registered in 8 of 19 countries.
Countries holding a registration under ATC L01XD07 (padeliporfin), each read from that country’s own register.
- This record: Belgium, from FAMHP / AFMPS (Belgium)
- 5 of them publish a price we can compare per daily dose
Padeliporfin · ATC L01XD07
8 / 19 countries
- Belgiumprice
- Czechiaprice
- Denmark
- Finlandprice
- Icelandprice
- Ireland
- Netherlands
- Polandprice
The record
At a glance
FAMHP / AFMPS (Belgium)- Active substance
- Padeliporfin Dipotassium
- Manufacturer
- Steba Biotech
- Country
- Belgium (BE)
- ATC code
- L01XD07
- ATC class
- Padeliporfin
- Defined daily dose
- 0.26 g, P
- Reimbursed
- Not published by this register
- Source register
- FAMHP / AFMPS (Belgium)
- Last checked
- September 26, 2026
Packs & prices · 0
No packs listed by the register for this record.
Regulatory notes
No shortage, Orange Book or US label notes for this record.
Same medicine, other countries
Padeliporfin in 7 other countries
What each register calls a product with the same active substance — salts and hydrates count as the same.
- CzechiaTOOKADSteba Biotech S.A., Luxembourg
- SpainTOOKAD 183 MG POLVO PARA SOLUCION INYECTABLESteba Biotech S.A.
- IcelandTookadSTEBA Biotech S.A.
- PolandTookadSteba Biotech S.A.
- SwedenTOOKAD 200 mg Pulver till injektionsvätska, lösningSteba Biotech
- FinlandTOOKADSteba Biotech S.A.
- IrelandTOOKAD 183 mg powder for solution for injectionSTEBA Biotech S.A.
Authorised across Europe · EMA
The same active substance is authorised in 3 EEA countries. Names it is sold under:
- Iceland · Tookad
- Liechtenstein · Tookad
- Norway · Tookad
Source: European Medicines Agency, Article 57 product data.
Sourced from a public register and reproduced with attribution. Drug Database is not affiliated with, endorsed by, or a partner of FAMHP / AFMPS (Belgium). This is an informational data service and not a medical device — verify against the official source of record before any clinical decision.
For developers
The same record over the API, and the raw payload
GET /v1/drugs/8db5cfbe-59b1-4b97-8d00-586c1ecc2242 GET /v1/drugs/8db5cfbe-59b1-4b97-8d00-586c1ecc2242?format=fhir
Every response carries last_synced_at, so freshness is a field rather than a promise. Below is exactly what the ingestion wrote, before any presentation — the same JSON the API returns under payload.
{
"form": "Powder for solution for injection",
"source": "afmps",
"status": "AUTHORIZED",
"name_en": "Tookad 183 mg",
"name_fr": "Tookad 183 mg",
"name_nl": "Tookad 183 mg",
"amp_code": "SAM520871-00",
"strengths": [
"183.0000"
],
"pack_count": 1,
"substances": [
"Padeliporfin Dipotassium",
"Padeliporfin",
"Mannitol"
],
"medicine_type": "ALLOPATHIC",
"atc_description": "Padeliporfin",
"authorisation_numbers": [
"EU/1/17/1228/001"
]
}See everything about padeliporfin.
This page is the registration. A free account adds the label text as the regulator wrote it, what it costs per daily dose across the markets that publish a price, a feed of what changes in the registers, and an assistant that answers with its sources. Interaction severity is free; mechanism and management are on the Growth plan. No card, nothing to install.